These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 18258868)

  • 41. GAO report says drug R & D costs rising, innovation decreasing.
    Consult Pharm; 2007 Mar; 22(3):257-8. PubMed ID: 17691159
    [No Abstract]   [Full Text] [Related]  

  • 42. Silent running: the race to the clinic.
    Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
    [No Abstract]   [Full Text] [Related]  

  • 43. Market watch: Therapeutic area 'heat map' for emerging markets.
    Gautam A; Li L; Srinivasan K
    Nat Rev Drug Discov; 2015 Aug; 14(8):518-9. PubMed ID: 26160486
    [No Abstract]   [Full Text] [Related]  

  • 44. Intellectual property. Research centers promise a break on medical patents in developing countries.
    Kean S
    Science; 2009 Nov; 326(5956):1051. PubMed ID: 19965400
    [No Abstract]   [Full Text] [Related]  

  • 45. King of the pill. Pfizer is the biggest drug company ever. Can it become the best?
    Simons J
    Fortune; 2003 Apr; 147(7):94-6, 100, 102. PubMed ID: 12698860
    [No Abstract]   [Full Text] [Related]  

  • 46. Research needs grants, funding and money--missing something?
    Ioannidis JP
    Eur J Clin Invest; 2012 Apr; 42(4):349-51. PubMed ID: 22050119
    [No Abstract]   [Full Text] [Related]  

  • 47. Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations.
    Truebel H; Thurston T
    Drug Discov Today; 2020 Dec; 25(12):2089-2094. PubMed ID: 33031944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tech transfer-slow progress.
    Lawrence S
    Nat Biotechnol; 2005 Jan; 23(1):12. PubMed ID: 15637603
    [No Abstract]   [Full Text] [Related]  

  • 49. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 50. The service-based bioeconomy.
    Nat Biotechnol; 2014 Jul; 32(7):597. PubMed ID: 25004205
    [No Abstract]   [Full Text] [Related]  

  • 51. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene patenting and medical research: a view from a pharmaceutical company.
    Stott M; Valentine J
    Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532
    [No Abstract]   [Full Text] [Related]  

  • 53. Public sector seeks to bridge 'valley of death'.
    Moran N
    Nat Biotechnol; 2007 Mar; 25(3):266. PubMed ID: 17344867
    [No Abstract]   [Full Text] [Related]  

  • 54. Medical research activities, funding, and creativity in Europe: comparison with research in the United States.
    Philipson L
    JAMA; 2005 Sep; 294(11):1394-8. PubMed ID: 16174700
    [No Abstract]   [Full Text] [Related]  

  • 55. Research funding. Philip Morris pulls the plug on controversial research program.
    Grimm D
    Science; 2008 Feb; 319(5867):1173. PubMed ID: 18309055
    [No Abstract]   [Full Text] [Related]  

  • 56. The CREATE Act: increasing costs associated with the biotech industry?
    Mills AE; Chen DT; Gillon JJ; Tereskerz PM
    Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pfizer swallows Wyeth, validates niche buster.
    Sheridan C
    Nat Biotechnol; 2009 Mar; 27(3):218-9. PubMed ID: 19270661
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent patent applications in angiogenesis research.
    Nat Biotechnol; 2006 Feb; 24(2):155. PubMed ID: 16465155
    [No Abstract]   [Full Text] [Related]  

  • 59. Exuberant unpredictability: sine qua non for priceless and prizeworthy biomedical research.
    Goldstein JL
    Nat Med; 2008 Oct; 14(10):1029-32. PubMed ID: 18841142
    [No Abstract]   [Full Text] [Related]  

  • 60. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.